Mary E. Wadlinger - Feb 23, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: Officer
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol: FMTX
Transactions as of: Feb 23, 2022
Transactions value $: -$45,798
Form type: 4
Date filed: 2/25/2022, 04:01 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Sale	-$45.8K	-4.68K	-3.36%	$9.78	135K	Feb 23, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.61 to $10.005. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

Officer Title: SVP, Corporate Affairs and Chief Human Resources Officer In a Form 4 filed by the reporting person on March 2, 2021, the box indicating "no longer subject to Section 16" was inadvertently checked. The reporting person has remained subject to Section 16, and all changes in beneficial ownership subsequent to such Form 4 have been properly reported on a timely basis.